Continuous dosing improves progression-free survival for melanoma patients with common mutations
A first-of-its-kind randomized clinical trial offers strong and perhaps surprising evidence that a combination of two targeted melanoma drugs when given continuously keeps patients' cancer from growing or spreading longer ...
Apr 27, 2020
0
1